Our Mission: Highlighting Innovations by showcasing breakthroughs in cancer research, including diagnostic tools, therapies, and preventive measures.

Bladder

Research has led to improvements in immunotherapy and non-invasive urine-based diagnostic tests, enhancing early detection and personalized treatment options.

Cellular

Study finds stem-like T cells key to lasting immune response in cancer, chronic diseases

Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline defenders—T cells—lose their ability to function effectively. Research, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) and the Peter MacCallum Cancer Center (Peter Mac), have identified a rare type of immune cells, called stem-like T cells, that holds the key to maintaining powerful, long-term immune responses.

Read More »
MEDICAL XPRESS

Tool gives more accurate estimates of recurrence risk and individual chemotherapy benefit in node-positive breast cancer

A new statistical tool that combines multiple clinical and pathologic factors with a patient’s 21-gene Oncotype DX Breast Recurrence Score result provides more accurate estimates about that patient’s breast cancer prognosis and their potential benefit from chemotherapy than either the Recurrence Score result or clinical factors alone.

Read More »
error: Content is protected !!